Insulin Aspart Protamine Injection and Larotrectinib Capsules
Determining the interaction of Insulin Aspart Protamine Injection and Larotrectinib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart Protamine Injection-Larotrectinib Oral Solution
- Insulin Aspart Protamine Injection-Larotrectinib Sulfate
- Insulin Aspart Protamine Injection-Lartruvo
- Insulin Aspart Protamine Injection-Larynex
- Insulin Aspart Protamine Injection-Laryng-O-Jet
- Insulin Aspart Protamine Injection-Laryngesic
- Larotrectinib Capsules-Insulin aspart, recombinant Subcutaneous
- Larotrectinib Capsules-Insulin degludec
- Larotrectinib Capsules-Insulin Degludec (U-100) Prefilled Pens
- Larotrectinib Capsules-Insulin Degludec (U-100) Vials
- Larotrectinib Capsules-Insulin Degludec (U-200) Prefilled Pens
- Larotrectinib Capsules-Insulin degludec and liraglutide